Flynn Zito Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$272K Buy
9,675
+219
+2% +$5.83K 0.09% 114
2025
Q4
$235K Buy
9,456
+214
+2% +$5.4K 0.08% 119
2025
Q3
$235K Buy
+9,242
New +$228K 0.09% 124
2024
Q4
Sell
-7,158
Closed -$207K 127
2024
Q3
$207K Sell
7,158
-6,383
-47% -$186K 0.1% 115
2024
Q2
$379K Sell
13,541
-4,293
-24% -$118K 0.19% 62
2024
Q1
$495K Sell
17,834
-1,637
-8% -$45.4K 0.26% 58
2023
Q4
$561K Sell
19,471
-882
-4% -$26.7K 0.38% 35
2023
Q3
$675K Buy
20,353
+1,411
+7% +$49.9K 0.47% 27
2023
Q2
$695K Buy
18,942
+103
+0.5% +$4.01K 0.47% 25
2023
Q1
$769K Sell
18,839
-912
-5% -$39.4K 0.56% 19
2022
Q4
$1.01M Sell
19,751
-616
-3% -$29.5K 0.85% 19
2022
Q3
$891K Buy
+20,367
New +$990K 0.88% 17
2022
Q2
Sell
-19,772
Closed -$1.02M 102
2022
Q1
$1.02M Buy
19,772
+9
+0% +$467 0.87% 20
2021
Q4
$1.16M Buy
+19,763
New +$979K 0.99% 19

Other funds holding PFE

Flynn Zito Capital Management's PFE Position: Q1 2026 in Review

Flynn Zito Capital Management increased its Pfizer (PFE) stake by 2.3% in Q1 2026, buying an estimated $5.83K and bringing the position to 9,675 shares worth $272K. The position accounts for 0.09% of the portfolio, ranked #114.

Flynn Zito Capital Management first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.16M in Q4 2021. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Flynn Zito Capital Management held 9,675 shares of Pfizer worth $272K as of Q1 2026.
  • Flynn Zito Capital Management bought 219 Pfizer shares in Q1 2026, an estimated $5.83K.
  • Pfizer made up 0.09% of Flynn Zito Capital Management's portfolio in Q1 2026, its #114 holding.
  • Flynn Zito Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
  • Flynn Zito Capital Management's Pfizer position peaked at $1.16M in Q4 2021.
  • 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Flynn Zito Capital Management's 13F filing for Q1 2026, filed 4 May 2026.